Time-limited trial of intensive care is more than merely life sustaining
Author:
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00134-022-06644-x.pdf
Reference5 articles.
1. Donaldson TM (2022) When the harms of intensive care treatment outweigh the benefits, the default use of time-limited trials is not ethically justifiable. Intensive Care Med. https://doi.org/10.1007/s00134-021-06607-8
2. Chang DW, Neville TH, Parrish J, Ewing L, Rico C, Jara L, Sim D, Tseng CH, van Zyl C, Storms AD, Kamangar N, Liebler JM, Lee MM, Yee HF Jr (2021) Evaluation of time-limited trials among critically ill patients with advanced medical illnesses and reduction of nonbeneficial ICU treatments. JAMA Intern Med 181(6):786–794. https://doi.org/10.1001/jamainternmed.2021.1000
3. Cheung EHL, Cheung JCH, Yip YY (2022) Raising awareness for time-limited trial discussion upon ICU triage and admission. Intensive Care Med 48(2):240–241. https://doi.org/10.1007/s00134-021-06590-0
4. Simonds AK (2003) Ethics and decision making in end stage lung disease. Thorax 58(3):272–277. https://doi.org/10.1136/thorax.58.3.272
5. Cheung EHL, Cheung JCH, Yip YY (2021) Partial code in cardiac arrest: should it be allowed as an exception? Chest 160(5):e541–e542. https://doi.org/10.1016/j.chest.2021.06.081
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Time-Limited Trials for Patients With Critical Illness;CHEST;2023-12
2. The Impact of Signing Do-Not-Resuscitate Orders on the Use of Non-Beneficial Life-Sustaining Treatments for Intensive Care Unit Patients: A Retrospective Study;International Journal of Environmental Research and Public Health;2022-08-03
3. Beyond failure or success: reflections on the ethical justifications for time-limited trial of intensive care;Intensive Care Medicine;2022-05-26
4. Death during life sustaining treatment must be considered a failure but can be acceptable if the treatment was proportional;Intensive Care Medicine;2022-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3